Cadoux Limited logo

Cadoux Limited (CCM)

Market Closed
CXA CXA
- Market Cap
- P/E Ratio
3.92% Div Yield
14,277 Volume
- Eps
Want to track CCM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

CCM closed Wednesday higher, an increase of 0% from Tuesday's close, completing a monthly decrease of -4.26%. Over the past 12 months, CCM stock lost -10%.
CCM pays dividends to its shareholders, with the most recent payment made on Jan 29, 2016. The next estimated payment will be in 29 Jan 2016 on Jan 29, 2016 for a total of A$9.9.
The last earnings report, released on Oct 14, 2024, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Cadoux Limited has completed 2 stock splits, with the recent split occurring on Jul 30, 2024.
The company's stock is traded on 3 different exchanges and in various currencies, with the primary listing on NYSE (USD).

Cadoux Limited (CCM) FAQ

On which exchange is it traded?

Cadoux Limited is listed on NYSE.

What is its stock symbol?

The ticker symbol is CCM.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 3.92%.

What is its market cap?

As of today, no market cap data is available.

Has Cadoux Limited ever had a stock split?

Cadoux Limited had 2 splits and the recent split was on Jul 30, 2024.

Cadoux Limited Profile

Health Care Providers & Services Industry
Healthcare Sector
Jianyu Yang CEO
CXA Exchange
US2062772049 ISIN
CN Country
595 Employees
29 Jan 2016 Last Dividend
16 Jan 2014 Last Split
- IPO Date

Overview

Concord Medical Services Holdings Limited, established in 1997 and headquartered in Beijing, the People's Republic of China, specializes in operating a network of radiotherapy and diagnostic imaging centers. Through its subsidiaries, the company services the healthcare needs in two main segments: Network and Hospital. It focuses on delivering advanced cancer treatment solutions and diagnostic services across its platforms, leveraging modern technology and clinical research to improve patient outcomes. The company also extends its expertise to clinical support, equipment leasing, management services, and operates specialty cancer hospitals providing a comprehensive range of medical services.

Products and Services

  • Linear Accelerators and External Beam Radiotherapy
  • These are cornerstone treatments in cancer therapy, focusing on the use of high-energy rays to target and destroy cancer cells. Concord Medical offers the latest technology in linear accelerators for precise treatment delivery.

  • Proton Therapy System
  • A cutting-edge cancer treatment that uses protons rather than x-rays to treat cancer. The proton therapy system allows for more precise targeting of tumor sites, minimizing damage to surrounding healthy tissues.

  • Gamma Knife Radiosurgery
  • This is a form of radiosurgery used to treat brain tumors, arteriovenous malformations, and other brain disorders. It's a minimally invasive procedure that offers high precision in targeting small areas within the brain.

  • Diagnostic Imaging Services
  • Concord Medical provides a wide range of diagnostic imaging services, including positron emission tomography-computed tomography (PET-CT) and magnetic resonance imaging (MRI) scanners. These technologies are essential for the accurate diagnosis and treatment planning of various diseases.

  • Clinical Support Services
  • The company aids in the development of treatment protocols, organizes joint diagnosis meetings, and supports clinical research to enhance treatment outcomes. Additionally, it assists in the recruitment and compensation determination for doctors and medical staff.

  • Equipment Leasing and Management Services
  • Offering radiotherapy and diagnostic equipment leasing, alongside management services, Concord Medical provides hospitals and healthcare facilities with access to state-of-the-art medical technology without the need for significant upfront investments.

  • Premium Cancer and Proton Treatment Services
  • These services are targeted towards hospitals seeking to offer high-end cancer treatment options, including specialized proton therapy, enhancing their capabilities in providing comprehensive cancer care.

  • Teleconsultation and Medical IT Services
  • Leveraging technology to bridge the gap in healthcare access, the company offers teleconsultation services and medical information technology solutions to improve patient care and operational efficiency.

  • Specialty Cancer Hospitals
  • Concord Medical operates specialty cancer hospitals that provide a full spectrum of services, from radiation therapy, diagnostic imaging, and laboratory tests to inpatient care and nursing services, focusing on delivering holistic cancer treatment.

Contact Information

Address: Tower A, Global Trade Center
Phone: 86 10 5903 6688